WASHINGTON - The U.S. system of institutional review boards (IRBs) is not properly protecting patients in clinical research and must be overhauled, according to a series of draft reports prepared by the Department of Health and Human Service's Office of the Inspector General.

The reports paint a picture of a system that has been overwhelmed by changes in the commercial and technological landscape.